RxDoctor Payments Data

Vernon Smith, MD

Internal Medicine · Lakewood, CONPI 1144294638

Payments from drug & device makers

$3,477in general payments, 2019–2025

Across 213 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$671
  • GSK$521
  • Lilly USA, LLC$329
  • Amgen$306
  • Johnson & Johnson$232
  • AstraZeneca$214
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$3,477100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,477 in reported general payments places this provider in the 90th percentile of 1,430 internal medicine providers in Colorado.

See all internal medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$84,775
Medicare patients
131
Services billed
1,161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide42$53,705
EliquisApixaban45$50,800
TrulicityDulaglutide21$34,339
XareltoRivaroxaban11$21,278
Bydureon BciseExenatide Microspheres14$19,826
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$16,139
MyrbetriqMirabegron14$14,315
Fluticasone-SalmeterolFluticasone Propion/Salmeterol44$5,363
Atorvastatin Calcium310$2,906
ShingrixVaricella-Zoster Ge/As01b/Pf12$2,649
Rosuvastatin Calcium203$2,556
Cephalexin20$2,484
Levothyroxine Sodium226$2,474
Adacel TdapDiph,pertuss(Acell),tet Vac/Pf32$2,224
Omeprazole72$1,817

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$329$88,04463 claims
PfizerEliquis$131$50,80045 claims
Johnson & JohnsonXarelto$232$21,27811 claims
GSKTrelegy Ellipta, Shingrix$521$18,78828 claims
Astellas Pharma US IncMyrbetriq$101$14,31514 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$44$2,474226 claims
AbbVieSynthroid$157$59812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,430 internal medicine providers in Colorado.

Other internal medicine in Lakewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →